C. Bal (Wien, Austria), M. Lommatzsch (Rostock, Germany)
Bronchodilator reversibility in patients with severe asthma included in the GAN registry.
K. Milger-Kneidinger (Munich, Germany), D. Skowasch (Bonn, Germany), E. Hamelmann (Bielefeld, Germany), C. Mümmler (Munich, Germany), M. Idzko (Vienna, Germany), C. Taube (Essen, Germany), A. Holtdirk (Hamm, Germany), H. Timmerman (Hamburg, Germany), R. Buhl (Mainz, Germany), S. Korn (Heidelberg und Mainz, Germany)
|  |
Interrelationships between body mass index, total IgE, and blood eosinophils count in healthy subjects
R. Amaral (Porto, Portugal), T. Jacinto (Porto, Portugal), A. Malinovschi (Uppsala, Sweden), C. Janson (Uppsala, Sweden), D. Price (Singapore, Singapore), J. Fonseca (Porto, Portugal), K. Alving (Uppsala, Sweden)
|  |
Bronchiectasis in severe asthma is associated with eosinophilic airway inflammation and activation
L. Frøssing (Copenhagen, Denmark), A. Von Bülow (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark)
| |
Increase in blood eosinophil count over time and sputum IL8 are associated with FEV1 decline in asthma
S. Graff (Liège, Belgium), C. Moermans (Liège, Belgium), S. Gerday (Liège, Belgium), M. Henket (Liège, Belgium), V. Paulus (Liège, Belgium), F. Guissard (Liège, Belgium), R. Louis (Liège, Belgium), F. Schleich (Liège, Belgium)
| |
Type 2 biomarker expression according to age of asthma onset: an analysis of the German severe asthma registry (GAN)
M. Lommatzsch (Rostock, Germany), C. Taube (Essen, Germany), E. Hamelmann (Bielefeld, Germany), K. Milger-Kneidinger (Munich, Germany), D. Skowasch (Bonn, Germany), M. Jandl (Hamburg, Germany), F. Schmitz (Kaiserslautern, Germany), C. Koerner-Rettberg (Wesel, Germany), M. Idzko (Vienna, Austria), R. Buhl (Mainz, Germany), S. Korn (Heidelberg, Germany)
| |
The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort
C. Bal (Vienna, Austria), M. Idzko (Vienna, Austria), K. Milger (Munich, Germany), D. Skowasch (Bonn, Germany), C. Schulz (Regensburg, Germany), C. Taube (Essen, Germany), E. Hamelmann (Bielefeld, Germany), R. Buhl (Mainz, Germany), S. Korn (Mainz, Germany)
| |
FeNO is not affected by spirometry, IOS or walking in healthy subjects or well controlled asthma patients
H. Andersen (Aarhus, Denmark), L. Pedersen (Aarhus, Denmark), M. Mousa (Aarhus, Denmark), N. Mousa (Aarhus, Denmark), A. Bjerrum (Aarhus, Denmark), T. Skjold (Aarhus, Denmark), T. Smidt-Hansen (Aarhus, Denmark), H. Hoffmann (Aarhus, Denmark), J. Schmid (Aarhus, Denmark)
| |
Association between Staphylococcal Enterotoxin (SE)-specific IgE and specific IgE for house dust mites (HDM) in Brazilian patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).
P. Campos Dos Santos (Rio De Janeiro (RJ), Brazil), S. Dortas Junior (Rio De Janeiro (RJ), Brazil), J. Elabras Filho (Rio De Janeiro (RJ), Brazil), F. Da Cruz (Rio De Janeiro (RJ), Brazil), S. Valle (Rio De Janeiro (RJ), Brazil), P. Ferraiolo (Rio De Janeiro (RJ), Brazil)
| |
Application of urinary proteomics for biomarker discovery in respiratory diseases
L. Martelo-Vidal (Santiago de compostela, Spain), S. Vázquez-Mera (Santiago de compostela, Spain), P. Miguéns-Suárez (Santiago de compostela, Spain), F. Salgado-Castro (Santiago de compostela, Spain), M. Blanco-Aparicio (A Coruña, Spain), M. Mosteiro-Añón (Vigo, Spain), G. Martínez-Capoccioni (Santiago de Compostela, Spain), P. Méndez-Brea (Santiago de Compostela, Spain), S. Bravo (Santiago de Compostela, Spain), F. González-Barcala (Santiago de Compostela, Spain), J. Nieto-Fontarigo (Santiago de Compostela, Spain)
| |
Overall response to anti-IL5/anti-IL5Ra treatment in severe asthma does not depend on initial bronchodilator responsiveness
C. Mümmler (München, Germany), H. Suhling (Hannover, Germany), N. Kneidinger (München, Germany), R. Buhl (Mainz, Germany), M. Kayser (Hannover, Germany), N. Drick (Hannover, Germany), J. Behr (München, Germany), T. Welte (Hannover, Germany), S. Korn (Mainz, Germany), K. Milger (München, Germany)
| |
Factors associated with middle-aged adult obstructive lung function deficits in the grass pollen season
S. Idrose (Melbourne, Australia), D. Vicendese (Melbourne, Australia), M. Abramson (Melbourne, Australia), E. Walters (Tasmania, Australia), G. Hamilton (Melbourne, Australia), A. Lowe (Melbourne, Australia), J. Douglass (Melbourne, Australia), C. Lodge (Melbourne, Australia), S. Dharmage (Melbourne, Australia)
| |
Polygenic risk score constituted by GWAS-identified disease markers helps predict asthma development
Y. Sio (Singapore, Singapore), F. Chew (Singapore, Singapore)
| |
The epidemiology of sensitization to perennial aeroallergens in adult patients with severe asthma in Belgium. The Belgian IgE (BEIgE) study
F. Schleich (Liège, Belgium), S. Gurdain (Vilvoorde, Belgium), E. Maury (Vilvoorde, Belgium), J. Van Schoor (Vilvoorde, Belgium)
| |
ICS-LABA prescribing in asthma (maintenance only and MART), clinical and symptom unmet need in Japan
S. Zhang (Collegeville, United States), A. Czira (Brentford, United Kingdom), J. Harley (Bollington, United Kingdom), K. Rothnie (Brentford, United Kingdom), L. Lee (Bollington, United Kingdom), M. Small (Bollington, United Kingdom)
| |
High prevalence of sensitisation to house dust mite in ethnic minority severe asthma patients
J. Kerks (Birmingham (West Midlands), United Kingdom), J. Marsh (Birmingham (West Midlands), United Kingdom), A. Bahron (Birmingham (West Midlands), United Kingdom), T. Krishna (Birmingham (West Midlands), United Kingdom), G. Walters (Birmingham (West Midlands), United Kingdom), F. O'Riordan (Birmingham (West Midlands), United Kingdom), L. White (Birmingham (West Midlands), United Kingdom), J. Sullivan (Birmingham (West Midlands), United Kingdom), A. Mansur (Birmingham (West Midlands), United Kingdom)
| |
Asthma comorbidities: frequency, risk factors, and associated burden in children and adolescents
S. Fasola (Palermo, Italy), G. Cilluffo (Palermo, Italy), V. Malizia (Palermo, Italy), L. Montalbano (Palermo, Italy), A. Licari (Pavia, Italy), G. Ferrante (Verona, Italy), G. Viegi (Pisa, Italy), S. La Grutta (Palermo, Italy)
| |
A comprehensive analysis of the components of the common weed pollens and related allergens in patients with allergic diseases in southern China
W. Luo (Guangzhou (Guangdong), China), B. Sun (Guangzhou (Guangdong), China)
| |
The impact of national lockdown in 2020 on admission rates for exacerbations in asthma; a nationwide cohort study.
L. Toennesen (Hvidovre and Herlev-Gentofte, Denmark), B. Bonnesen (Herlev-Gentofte, Denmark), P. Sivapalan (Herlev-Gentofte, Denmark), A. Jordan (Herlev-Gentofte, Denmark), M. Saeed (Herlev-Gentofte , Denmark), J. Eklöf (Herlev-Gentofte , Denmark), C. Ulrik (Hvidovre K, Denmark), K. Skaarup (Herlev-Gentofte, Denmark), M. Lassen (Herlev-Gentofte, Denmark), T. Biering-Sørensen (Herlev-Gentofte, Denmark), J. Jensen (Herlev-Gentofte, Denmark)
| |
Clinico-demographic, radiological and immunological profile of allergic bronchopulmonary aspergillosis in a tertiary care institute of east India.
M. Shankar (Patna, India), A. Ejazi (Patna, India), S. Chaubey (Patna, India), D. Kumar (Patna, India)
| |
Inflammatory phenotypes and comorbidities in mild-to-moderate COPD
T. Soumagne (Paris, France), S. Hue (Créteil, France), J. Dalphin (Besançon, France), B. Degano (Grenoble, France)
| |